In conclusion we have demonstrated that vaccination of minimum aged dogs with a multivalent vaccine containing the CPV-2b variant strain will induce serological responses which are cross-reactive againstall currently circulating field strains, CPV-2a and CPV-2c, and the now extinct field strain CPV-2.